AmerisourceBergen completes acquisition of PharmaLex

""

AmerisourceBergen Corporation has completed its acquisition of PharmaLex Holding, a provider of tech-enabled services from clinical development consulting to marketing authorisation. 

PharmaLex is a global team of scientific, regulatory and safety and compliance (GxP) experts that provide strategic guidance and regulatory support to biopharma companies throughout a product’s lifecycle. 

The acquisition of PharmaLex’s regulatory affairs, development consulting and scientific affairs, pharmacovigilance, and quality management and compliance services will enhance AmerisourceBergen’s platform of pharma manufacturer services. 

Willis Chandler, President of Global Pharma Services, AmerisourceBergen, commented: “Together we will expand on each other’s capabilities to deliver an industry leading customer experience and help our partners achieve the outcomes they desire.”  

Thomas Dobmeyer, CEO and Managing Partner, PharmaLex, added: “We look forward to working with our new colleagues and building on each other’s capabilities as we pursue our shared commitment of creating healthier futures.” 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free